IP Library Granted Patent US 11,111,495
Granted Patent B2
US 11,111,495 · App. 16/414,026 · Granted Sep 7, 2021

Method for generating aptamers with improved off-rates

Inventors: Dominic Zichi (Boulder, CO); Sheri K. Wilcox (Longmont, CO); Chris Bock (Cleveland Heights, OH); Daniel J. Schneider (Arvada, CO); Bruce Eaton (Longmont, CO); Larry Gold (Boulder, CO)
Assignee: Somalogic, Inc.
C12N15/115C12N9/6429C12N15/1048C12Q1/6811C12Q1/6816C12Q1/6832C12Q1/6834G01N33/5308G01N33/58C12N2310/16C12N2310/314C12N2310/315C12N2310/321C12N2310/322C12N2310/333C12N2310/334C12N2310/335C12N2310/336C12N2330/31
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,111,495
App. No.
16/414,026
Granted
Sep 7, 2021
Kind
B2
Abstract

The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.

Claims (5)

1. A non-covalent complex of an aptamer and a target molecule, wherein the aptamer comprises at least one 5-position modified pyrimidine having a hydrophobic group attached via a linker to the 5-position of the pyrimidine, and wherein the aptamer has binding affinity for the target molecule.

2. The non-covalent complex of claim 1 , wherein the hydrophobic group is selected from the group consisting of a benzyl, iso-butyl, indole and naphthyl.

3. The non-covalent complex of claim 1 , wherein the 5-position modified pyrimidine is a 5-position modified uridine or cytosine.

4. The non-covalent complex of claim 1 , wherein the target molecule is a protein or peptide.

5. The non-covalent complex of claim 1 , wherein the linker is selected from the group of linkers consisting of:

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jan 14, 2022
From: SOMALOGIC, INC.; SOMALOGIC OPERATING CO., INC.
To: SOMALOGIC OPERATING CO., INC.
Reel/Frame 058736/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2019
From: ZICHI, DOMINIC; WILCOX, SHERI K.; BOCK, CHRIS; SCHNEIDER, DANIEL J.; EATON, BRUCE; GOLD, LARRY
To: SOMALOGIC, INC.
Reel/Frame 049295/0278 →
Continuity (13)
Continuation 15878161 · Jan 23, 2018
Continuation 15410414 · Jan 19, 2017
Continuation 14610758 · Jan 30, 2015
Continuation 13113261 · May 23, 2011
Division 12175434 · Jul 17, 2008
Continuation In Part 60950283 · Jul 17, 2007
Continuation In Part 11623535 · Jan 16, 2007
Continuation In Part 11623580 · Jan 16, 2007
Provisional Application 61051594 · May 8, 2008
Provisional Application 61031420 · Feb 26, 2008
Provisional Application 60950293 · Jul 17, 2007
Provisional Application 60950281 · Jul 17, 2007
Related Publication 20190330634A1 · Oct 31, 2019